AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Noriyuki Yamaotsu |
| Publication date | December 9, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |